Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.572,07
-0,76%
NASDAQ
17.436,10
-0,18%
Bitcoin
82.911,82
5,66%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GoodRx Holdings Inc (GDRX) GoodRx Holdings Inc (GDRX) Notizie

GoodRx Holdings Inc

GDRX
4,56
0,07 (1,56%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 21:08:10
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202522:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202523:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202522:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202522:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202512:05BWGoodRx Reports Fourth Quarter and Full Year 2024 Results
27/2/202512:02EDGAR2Form 8-K - Current report
18/2/202515:00BWGoodRx Achieves HITRUST i1 Certification to Manage Data..
11/2/202523:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202522:09EDGAR2Form 8-K - Current report
05/2/202522:05BWGoodRx Appoints Christopher A. McGinnis as Chief Financial..
30/1/202522:05BWGoodRx Announces Date for Fourth Quarter and Full Year 2024..
22/1/202523:02EDGAR2Form 8-K - Current report
22/1/202523:00BWScott Wagner Joins GoodRx Board of Directors
15/1/202523:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202515:05EDGAR2Form 8-K - Current report
10/1/202517:00BWGoodRx Offering Free Telehealth Appointments to Los Angeles..
09/1/202500:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202501:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:22EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
18/12/202422:05BWGoodRx to Participate in the 43rd Annual J.P. Morgan..
17/12/202415:00BWGoodRx Report Shows Millions at Risk as Endocrinologist..
16/12/202422:15EDGAR2Form 8-K - Current report
16/12/202422:05BWGoodRx Appoints Healthcare Industry Veteran, Wendy Barnes,..
10/12/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202415:00BWGoodRx Reveals Americans Overspent on Weight Loss..
13/11/202418:38PRNUSKuehn Law Encourages Investors of GoodRx Holdings, Inc. to..
12/11/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202420:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202412:05BWGoodRx Reports Third Quarter 2024 Results
07/11/202412:01EDGAR2Form 8-K - Current report
04/11/202422:05BWGoodRx to Participate in Upcoming Investor Conferences
31/10/202414:00BWGoodRx Unveils New E-commerce Platform, Launches with Opill®
29/10/202414:00BWGoodRx Announces Exclusive Low Cash Price for QSYMIA®, the..
28/10/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202413:08EDGAR2Form 8-K - Current report
28/10/202413:00BWRonald E. Bruehlman Joins GoodRx Board of Directors
23/10/202415:00BWGoodRx Announces New Affordability Programs for Menopause..
18/10/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202415:00BWGoodRx Partnering with Retail Pharmacies to Deliver..
10/10/202423:41BWGoodRx Announces Date for Third Quarter 2024 Earnings..
26/9/202415:00BWGoodRx Announces Lowest Discounted Cash Price at Retail..
10/9/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:43EDGAR2Form 144 - Report of proposed sale of securities
21/8/202422:05BWGoodRx to Participate in Upcoming Investor Conferences
14/8/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 4,47 Min: 4,43 Max: 4,61
Chiusura: 4,49

La tua Cronologia

NASDAQ
GDRX
GoodRx
EU
YIEL
Amundi EUR High Yield Co...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci